Gelstat appoints president
This article was originally published in The Tan Sheet
Executive Summary
William Colucci is appointed president, a newly created position, the OTC marketer announces Sept. 5. Colucci's knowledge and relationship in the financial community will play a key role in the firm's long-term strategies, the company notes. "We expect that Bill's experience analyzing business processes and improving operation performance coupled with [marketing efforts] will dramatically accelerate our pace to return GelStat to profitability," CEO and Chairman James LaFlamme says in a statement. The firm markets GelStat brand OTC treatments for pain and inflammation in retail chains, independent retailers, pharmacies and direct-to-consumer channels...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.